Can 18F-FDG PET/CT predict EGFR status in patients with non-small cell lung cancer? A systematic review and meta-analysis
B Du, S Wang, Y Cui, G Liu, X Li, Y Li - BMJ open, 2021 - bmjopen.bmj.com
Objectives This study aimed to explore the diagnostic significance of 18F-
fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/CT for predicting the …
fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/CT for predicting the …
[HTML][HTML] Automated detection and classification of tumor histotypes on dynamic PET imaging data through machine-learning driven voxel classification
G Bianchetti, S Taralli, M Vaccaro, L Indovina… - Computers in Biology …, 2022 - Elsevier
deoxy-2-fluorine-(18 F) fluoro-d-glucose Positron Emission Tomography/Computed
Tomography (18 F-FDG-PET/CT) is widely used in oncology mainly for diagnosis and …
Tomography (18 F-FDG-PET/CT) is widely used in oncology mainly for diagnosis and …
Minor components of micropapillary and solid subtypes in lung invasive adenocarcinoma (≤ 3 cm): PET/CT findings and correlations with lymph node metastasis
C Chang, X Sun, W Zhao, R Wang, X Qian, B Lei… - La radiologia …, 2020 - Springer
Objective To investigate the PET/CT findings in lung invasive adenocarcinoma with minor
components of micropapillary or solid contents and its association with lymph node …
components of micropapillary or solid contents and its association with lymph node …
SUVmax of 18FDG PET/CT predicts histological grade of lung adenocarcinoma
XY Sun, TX Chen, C Chang, HH Teng, C Xie… - Academic …, 2021 - Elsevier
Objectives The relationship between the 18 FDG PET-CT maximum standard uptake value
(SUVmax) and the type of lung adenocarcinoma is still not established. The aim of this study …
(SUVmax) and the type of lung adenocarcinoma is still not established. The aim of this study …
Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epidermal growth factor receptor mutation status
T Isaka, H Ito, T Yokose, H Saito, H Adachi, K Murakami… - BMC cancer, 2022 - Springer
Abstract Background Pathological stage IB-IIIA lung adenocarcinoma with an epidermal
growth factor receptor (EGFR) mutation (Mt) has a high recurrence rate even after complete …
growth factor receptor (EGFR) mutation (Mt) has a high recurrence rate even after complete …
Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC
BG Ackerson, BC Tong, JC Hong, L Gu, J Chino… - Lung Cancer, 2018 - Elsevier
Purpose To compare sublobar resection and stereotactic body radiation therapy (SBRT) in
patients with stage I non-small cell lung cancer (NSCLC). Methods Patients undergoing …
patients with stage I non-small cell lung cancer (NSCLC). Methods Patients undergoing …
The diagnostic and predictive efficacy of 18F-FDG PET/CT metabolic parameters for EGFR mutation status in non-small-cell lung cancer: a meta-analysis
Y Guo, H Zhu, Z Yao, F Liu, D Yang - European Journal of Radiology, 2021 - Elsevier
Purpose To investigate the predictive performance of the maximum standardized uptake
value (SUV max) and mean standardized uptake value (SUV mean) of primary lesions …
value (SUV max) and mean standardized uptake value (SUV mean) of primary lesions …
Glucose and glutamine metabolism in relation to mutational status in NSCLC histological subtypes
TWH Meijer, MG Looijen‐Salamon, J Lok… - Thoracic …, 2019 - Wiley Online Library
Background Both hypoxia and oncogenic mutations rewire tumor metabolism. In this study,
glucose and glutamine metabolism‐related markers were examined in stage I‐resectable …
glucose and glutamine metabolism‐related markers were examined in stage I‐resectable …
FDG-PET/CT for pretherapeutic lymph node staging in non-small cell lung cancer: a tailored approach to the ESTS/ESMO guideline workflow
JMM Rogasch, N Frost, S Bluemel, L Michaels… - Lung cancer, 2021 - Elsevier
Objectives In patients with NSCLC, current ESTS and ESMO guidelines recommend
invasive lymph node (LN) staging with EBUS-TBNA even if FDG-PET/CT is negative for …
invasive lymph node (LN) staging with EBUS-TBNA even if FDG-PET/CT is negative for …
CT radiomics analysis of lung cancers: differentiation of squamous cell carcinoma from adenocarcinoma, a correlative study with FDG uptake
Y Tomori, T Yamashiro, H Tomita… - European journal of …, 2020 - Elsevier
Background and purpose Pulmonary squamous cell carcinoma (SCC) was reported to have
significantly higher histogram_kurtosis obtained by unenhanced computed tomography (CT) …
significantly higher histogram_kurtosis obtained by unenhanced computed tomography (CT) …